We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
PMRS claims that the FDA’s repeated approval of opioids for chronic pain with insufficient evidence of efficacy is a major driving factor behind the ongoing opioid crisis. Read More
The bribes and kickbacks took multiple forms, according to the filing, including paying the salaries of practitioners’ office staff for administrative tasks they would otherwise have had to pay themselves. Read More
RiteAid has agreed to pay $300,000 to settle claims its Rhode Island stores filled prescriptions greater than the 100 dosage units allowed by law. Read More
A federal court has issued an injunction against cuts to 340B payments introduced last January by the Centers for Medicare and Medicaid Services. Read More
As the federal government shutdown nears the two-week mark, FDA Commissioner Scott Gottlieb continued to issue updates via Twitter in the absence of normal media communications by the agency. Read More
The bureau said it found “insufficient evidence to conclude that the elements of the RevAid program that limit distribution to generics are anti-competitive.” Read More
Democratic legislators, including some possible 2020 presidential contenders, are planning to highlight the hot-button issue of drug pricing in the 116th Congress — although the first order of business will be ending the federal government shutdown. Read More
The motion claims the two attorneys general disclosed details about a forthcoming complaint whose details they did not share with the court or defense. Read More